Oakworth Capital Inc. lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,816 shares of the company’s stock after purchasing an additional 330 shares during the period. […]

Raleigh Capital Management Inc. raised its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,471 shares of the company’s stock after buying an additional 463 shares during the period. […]

Calton & Associates Inc. lifted its stake in shares of Phillips Edison & Company, Inc. (NASDAQ:PECO – Free Report) by 1.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,233 shares of the company’s stock after buying an additional 641 shares during the […]

Prentiss Smith & Co. Inc. lessened its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 0.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 48,357 shares of the company’s stock after selling 456 shares during the period. Novartis accounts for approximately 3.6% […]